XML 25 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Preferred Shares
Preferred Shares
Series A Preferred Stock
Common Shares
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series A Preferred Stock
Accumulated Deficit
Balance at Dec. 31, 2014 $ (88,448)       $ 143,113 $ (217) $ 738,890   $ (970,234)
Balance (in shares) at Dec. 31, 2014         174,610,451 (20,079)      
Issuance of stock   $ 57,853   $ 29,168       $ 28,685  
Issuance of stock (shares)       391,017,970          
Conversion of Series A Convertible Preferred Stock, net (187)   $ (4,804)   $ 4,804   (187)    
Conversion of Series A Convertible Preferred Stock, net (in shares)     (62,833,330)   6,283,333        
Preferred stock purchase option 946           1,814   (868)
Preferred stock beneficial conversion features             32,987   (32,987)
Exercise of warrants $ 2,713       $ 1,429   1,284    
Exercise of warrants (in shares) 1,844,585       1,844,585        
Exercise of stock options $ 31       $ 13   18    
Exercise of stock options (in shares)         18,020        
Vesting of restricted stock units (194)       $ 619 $ (194) (619)    
Vesting of restricted stock units (in shares)         821,376 (154,423)      
Reacquisition of conversion option in convertible notes (1,300)           (1,300)    
Tax benefits realized from stock-based compensation 727           727    
Stock-based compensation 13,872           13,872    
Net loss (115,204)               (115,204)
Balance (Scenario, Previously Reported) at Dec. 31, 2015 (129,191)   $ 24,364   $ 149,978 $ (411) 816,171   (1,119,293)
Balance (Cumulative-effect adjustment) 1,639               1,639
Balance at Dec. 31, 2015 (127,552)   $ 24,364   $ 149,978 $ (411) 816,171   (1,117,654)
Balance (in shares) (Scenario, Previously Reported) at Dec. 31, 2015     328,184,640   183,577,765 (174,502)      
Balance (in shares) at Dec. 31, 2015     328,184,640   183,577,765 (174,502)      
Issuance of stock 64,613       $ 15,712   48,901    
Issuance of stock (shares)         24,265,000        
Exchange of exchangeable senior notes, net of transaction costs 127,436       $ 40,062   87,374    
Conversion of Series A Convertible Preferred Stock, net (in shares)         60,311,188        
Exercise of stock options $ 287       $ 119   168    
Exercise of stock options (in shares) 177,146       177,146        
Vesting of restricted stock units $ (1,094)       $ 1,295 $ (1,087) (1,302)    
Vesting of restricted stock units (in shares)         1,852,102 (645,003)      
Stock-based compensation 13,602           13,602    
Net loss (86,350)               (86,350)
Balance at Dec. 31, 2016 (9,058)   $ 24,364   $ 207,166 $ (1,498) 964,914   (1,204,004)
Balance (in shares) at Dec. 31, 2016     328,184,640   270,183,201 (819,505)      
Exercise of stock options $ 638       $ 229   409    
Exercise of stock options (in shares) 356,656       356,656        
Vesting of restricted stock units $ (2,767)       $ 1,373 $ (2,731) (1,409)    
Vesting of restricted stock units (in shares)         2,179,187 (877,528)      
Stock-based compensation 13,952           13,952    
Net loss (67,865)               (67,865)
Balance at Dec. 31, 2017 $ (65,100)   $ 24,364   $ 208,768 $ (4,229) $ 977,866   $ (1,271,869)
Balance (in shares) at Dec. 31, 2017     328,184,640   272,719,044 (1,697,033)